IHE iShares US Pharmaceuticals ETF
DJ US Select Pharms TR USD

NAV as of 07-Dec-2022

186.1167

4 Week: 180.16 - 189.96

52 Week: 167.98 - 201.82

Latest Closing Price

186.21

Premium / Discount

-0.24

Expense Ratio

0.39%

Investment Objective

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
iShares
Asset Under Management:
416,532,771
Launch Date:
30/04/2006
Asset Class:
Equity
Replication Method:
Physical-Sample
Number of Holdings:
44
Trading Currency:
USD
Style:
Large Value
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-6.081.15-5.29
1 Day0.690.000.00
1 Week-0.992.30-0.43
1 Month4.284.420.97
3 Months3.699.210.40
6 Months-4.0513.14-0.31
1 Year-0.5518.07-0.03
2 Years6.1921.990.28
3 Years22.4536.370.62
5 Years22.1443.790.51
10 Years116.5359.751.95

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 13.400440.521929.74698.8160-11.721710.6598-7.672115.490113.818212.8271
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 90.000087.000031.000035.000059.0000100.000079.000097.000080.000039.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
20/12/201627/12/20160.3377
20/06/201626/06/20160.3336
23/12/201430/12/20140.3856
23/09/201429/09/20140.3937
23/06/201429/06/20140.7593
24/03/201430/03/20140.2794
26/12/201302/01/20140.0628
22/12/201329/12/20130.2748
23/09/201329/09/20130.2897
25/06/201301/07/20130.3263

Portfolio Data

Total Number of Holdings: 44

Number of Bond Holdings: 0

Number of Equity Holdings: 40

Total Market Value: 416,532,771

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Johnson & Johnson23.6408559,180098,471,598
2Pfizer Inc19.99631,675,543083,291,243

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant59.49
Large4.20
Medium15.25
Small15.82
Micro4.98

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

11.3472

Price/Book*

2.9549

Price/Sales*

2.6919

Price/Cash Flow*

8.3566

Dividend Yield*

2.3976

Growth Measures

Long-Term Earnings

6.5154

Historical Earnings

35.1680

Sales Growth

1.3802

Cash-Flow Growth

14.6522

Book-Value Growth

5.2598

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.